NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Steven M Dubinett

The UCLA-Boston University Lung Cancer Biomarker Development Laboratory

Trachea, bronchus and lung

Pathology

Rachael Rigby

Suppressor of cytokine signaling 3 is a key regulator of intestinal epithelial homeostasis

Colorectum

Frank B Hu

Harvard Transdisciplinary Research in Energetics and Cancer Center

Colorectum Prostate

Mark Thursz

Prolifica (Prevention of Liver Fibrosis and Cancer in Africa)

Liver and intrahepatic bile ducts

Pathology

Clemence Pinel

The construction of the environment in epigenetics research - A social science exploration

Breast

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Ajit P Varki

Oligosaccharies of Normal and Malignant Cells

Colorectum Breast

Sara Lindstroem

The Genetic Architecture of Breast Cancer Risk Factors and Breast Cancer

Breast

Ian Tannock

Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer

Prostate